Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
261
-
262
-
263
-
264
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
265
-
266
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
267
-
268
-
269
-
270
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
271
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
272
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
273
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
274
-
275
-
276
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
277
Digital Microfluidic Platform Based on Printed Circuit Board for Affinity Evaluation of Mertansine Aptamers
Published 2025“…Compared with manual methods, the digital microfluidic platform not only reduced the time for a single determination from 105 to 45 min but also significantly decreased the reagent consumption from 1280 to 30.72 μL. …”
-
278
Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization
Published 2025“…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”
-
279
-
280